Urte Gayko
Corporate Officer/Principal at SUMMIT THERAPEUTICS INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mahkam Zanganeh | M | 52 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 4 years |
| Robert Duggan | M | 79 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 5 years |
| Robert Bradway | M | 61 | 18 years | |
| Elaine C. Stracker | M | 64 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 5 years |
| Manmeet Singh Soni | M | 46 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 5 years |
| Alessandra Cesano | M | 63 |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | 9 years |
| Ujwala Mahatme | F | 59 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 4 years |
| Kenneth Clark | M | 65 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 3 years |
| Glyn Owain Edwards | M | 68 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 12 years |
| Shelley Spray | F | 59 | 3 years | |
| Robert Booth | M | 70 | 2 years | |
| Robert Eckert | M | 69 | 21 years | |
| David Reese | M | 61 | 19 years | |
| Richard Vickers | M | 48 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 21 years |
| Matthew Busch | M | 50 | 20 years | |
| Esteban Santos | M | 56 | 17 years | |
| David Powell | M | 55 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | 2 years |
| Dave Gancarz | M | - | - | |
| Allen Yang | M | - | 1 years | |
| Will Black | M | - | - | |
| Hugh O’Neill | M | - |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | - |
| Michelle Xia | M | 57 | 1 years | |
| Jos Houbiers | M | - |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | - |
| Mike Zahigian | M | - | 23 years | |
| Derek Miller | M | - | 21 years | |
| Campbell Hair | M | - | 4 years | |
| Fong Clow | M | 67 | 1 years | |
| Howard West | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Parkinson | M | 73 |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | 9 years |
| Pamela Wapnick | F | 58 | 9 years | |
| Dennis Fenton | M | 72 | 27 years | |
| Paul Eisenberg | M | - | 14 years | |
| David W. Beier | M | 75 | 10 years | |
| Michael Kelly | M | 67 | 14 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| William Ashton | M | 73 | 16 years | |
| Philip McGarrigle | M | - |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | - |
| James Daly | M | 63 | 9 years | |
| Preston Klassen | M | 55 | 7 years | |
| Sean B. W. Martin | M | 61 | - | |
| John Moriarty | M | 56 | 6 years | |
| Diana McKenzie | F | 59 | 12 years | |
| Sean E. Harper | M | 61 | 16 years | |
| Gregory L. Tewalt | M | - | - | |
| William P. Sheridan | M | 69 | 5 years | |
| Michael Severino | M | 58 | 10 years | |
| Vasant Prakash Gandhi | M | - | 5 years | |
| Craig Shepherd | M | - | 7 years | |
| Cynthia Patton | F | 62 | 15 years | |
| Thomas Zindrick | M | 65 | 8 years | |
| Willard Dere | M | 70 | 11 years | |
| Susan Lundeen Smuck | F | 57 | 12 years | |
| Erin Lavelle | F | 46 | 15 years | |
| Andreas Grauer | M | 63 | - | |
| Ankur Dhingra | M | 48 | 2 years | |
| Nathan Hardy | M | 48 | 10 years | |
| Rachel Lenington | F | 51 | 10 years | |
| Frank J. Biondi | M | 79 | 15 years | |
| Leonard Schaeffer | M | 78 | 9 years | |
| Cynthia Flowers | F | 64 | 5 years | |
| Timothy Martin | M | 55 | 3 years | |
| Anna Richo | F | 63 | - | |
| Dominique Monnet | M | 65 | 11 years | |
| Patricia Cary Sueltz | F | 71 | 2 years | |
| J. Reason | M | 83 | 12 years | |
| Michael Goldberg | M | 66 |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | - |
| Vance D. Coffman | M | 79 | 9 years | |
| Frank Herringer | M | 81 | 15 years | |
| Thomas O'Neil | M | 59 |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | 2 years |
| Brian M. McNamee | M | 67 | - | |
| John Smither | M | 71 | 6 years | |
| David J. Scott | M | 71 | - | |
| George Morrow | M | 72 | 10 years | |
| Jin Long Chen | M | 61 | 4 years | |
| Doug Farrar | M | 59 | 7 years | |
| Brian Kotzin | M | 74 | 11 years | |
| Catherine Stehman-Breen | M | 61 | 12 years | |
| Timothy Powers | M | 58 | 5 years | |
| Eliot Charles | M | 62 | 3 years | |
| Deepak Nath | M | - | - | |
| Oranee T. Daniels | M | - | - | |
| Terry Rosen | M | 65 | 9 years | |
| Marc D. Better | M | 68 | 5 years | |
| Gisela Schwab | M | 67 | 7 years | |
| Sandra Milligan | M | 60 | 10 years | |
| Warren Wayne Myers | M | 62 | 10 years | |
| Majed Kheir | M | 46 | 6 years | |
| Steven J. Ruhl | M | - | - | |
| David Hallal | M | 56 | 10 years | |
| Richard Paulson | M | 56 | 10 years | |
| Denny Lanfear | M | 68 | 13 years | |
| Michael Narachi | M | 64 | 20 years | |
| Peter K. Watler | M | 62 | 12 years | |
| Bradley J. Maroni | M | 71 | 6 years | |
| Timothy Hoey | M | 65 | - | |
| Carl LeBel | M | 65 | 10 years | |
| Eric Grinstead | M | 66 | 7 years | |
| Giuseppe Giorgini | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 94 | 95.92% |
| United Kingdom | 11 | 11.22% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Urte Gayko
- Personal Network
